Chinese RMs Outperform US RMs, But Neither Does Particularly Well
Chinese reverse mergers (CRM) have a bad reputation with investors. There have been so many fraud allegations over the years that shorting CRMs was practically an investment strategy at one point, and in 2011 the Securities and Exchange Commission warned investors to be wary of reverse mergers (RM) across the board. New research says that this avoidance may be unwarranted because CRMs actually outperform US RMs and non-RM stocks with similar characteristics, though their absolute results don’t have much to recommend them.
CRMs did better than RMs, but neither is impressive
To track relative performance researchers matched up . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click Chat.